London, x, NW10 7EW,
United Kingdom
Hammersmith Medicines Research Ltd. Technographics
Hammersmith Medicines Research Ltd. Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Hammersmith Medicines Research Ltd. and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 200 Hammersmith Medicines Research Ltd. employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Hammersmith Medicines Research Ltd. has purchased the following applications: Microsoft 365 for Collaboration in 2019, Packet Tide ExpressionEngine CMS (ex EllisLab) for Web Content Management in 2015, DreamHost for Application Hosting and Computing Services in 2014 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Hammersmith Medicines Research Ltd. is running and its propensity to invest more and deepen its relationship with Microsoft , Packet Tide , DreamHost or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Hammersmith Medicines Research Ltd. revenues, which have grown to $16.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Hammersmith Medicines Research Ltd. intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Hammersmith Medicines Research Ltd. Tech Stack and Enterprise Applications
Hammersmith Medicines Research Ltd. Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft 365 | Collaboration | Collaboration | n/a | 2019 | 2019 |
In 2019, Hammersmith Medicines Research Ltd. deployed Microsoft 365 as its Collaboration platform and lists Microsoft 365 on its public website, indicating active provisioning of the suite for corporate collaboration and client-facing communications. The presence of Microsoft 365 on the company website confirms the application name Microsoft 365 and aligns the deployment with the Collaboration category for Hammersmith Medicines Research Ltd.
The implementation aligns with standard Microsoft 365 Collaboration capabilities, including email and calendaring, real time chat and meetings, document management and intranet capabilities, and endpoint file synchronization. Microsoft 365 is referenced in ways consistent with Exchange Online for organization email, SharePoint Online for team sites and document libraries, OneDrive for individual file sync, and Teams for meetings and collaboration, reflecting category-aligned functional modules and workflows.
Operationally the Microsoft 365 deployment is positioned to support corporate collaboration across Hammersmith Medicines Research Ltd. in the United Kingdom and its roughly 200 employees, using Microsoft 365 administrative controls, role based access administration, and built in compliance features typical for clinical research environments. Governance signals on the site suggest centralized provisioning and standard Microsoft identity and access management patterns to manage users and mail routing, while the public reference indicates the platform is integrated into both internal collaboration and outward facing communication channels.
|
Hammersmith Medicines Research Ltd. Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Packet Tide | Legacy | Packet Tide ExpressionEngine CMS (ex EllisLab) | Web Content Management | Content Management | n/a | 2015 | 2015 |
In 2015 Hammersmith Medicines Research Ltd implemented Packet Tide ExpressionEngine CMS ex EllisLab for Web Content Management on its public website in the United Kingdom. The deployment anchors the company website on a CMS-driven content model to manage pages, news, and static clinical information for external audiences.
Packet Tide ExpressionEngine CMS ex EllisLab was configured with template-driven front end rendering, channel based content structures, an asset manager for images and documents, and role based user permissions to support editorial workflows. Standard Web Content Management capabilities such as content entry forms, scheduled publishing, versioning, and template partials were used to structure site content and enforce consistent presentation.
Operationally the implementation supports the marketing and communications function and the web operations team who manage ongoing updates and publishing cadence across the site. Integration points are limited to the website delivery layer and internal editorial tooling, with the CMS acting as the central authoring and publishing system for site content.
Governance was established through role assignments and approval workflows to control publishing and content changes, and the rollout was executed against the existing public site content to centralize content management under Packet Tide ExpressionEngine CMS. The configuration emphasizes maintainable templates and editorial controls typical of Web Content Management implementations.
|
Hammersmith Medicines Research Ltd. IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| DreamHost | Legacy | DreamHost | Application Hosting and Computing Services | IaaS | n/a | 2014 | 2014 |
In 2014 Hammersmith Medicines Research Ltd. implemented DreamHost to provide Application Hosting and Computing Services for its corporate website. The deployment uses DreamHost as the primary hosting platform to deliver web content and public facing application hosting for Hammersmith Medicines Research Ltd., with DreamHost handling the site’s HTTP delivery and basic compute for web assets.
Configuration and operational coverage align with standard Application Hosting and Computing Services capabilities, including web server provisioning, DNS management, SSL certificate lifecycle, and persistent storage for site assets. Operational governance centers on website ownership and content deployment workflows, with routine tasks expected around domain management, certificate renewal, and content publishing to the DreamHost hosted environment.
|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2019 | 2019 |
|
Hammersmith Medicines Research Ltd. CyberSecurity
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Secure Email Gateways (SEGs) | CyberSecurity |
|
2020 | 2020 |
|
IT Decision Makers and Key Stakeholders at Hammersmith Medicines Research Ltd.
Apps Being Evaluated by Hammersmith Medicines Research Ltd. Executives
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||